Bayer Reveals Latest Prostate Cancer Data at 2024 ASCO GU Cancers Symposium

WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer will present new data across its prostate cancer portfolio at the upcoming American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place January 25-27, 2024 in San Francisco, California. These presentations underscore Bayer’s commitment to advance prostate cancer care. NUBEQA® (darolutamide) data includes post hoc…
Click here to view original post